sun-dragon
   ACHV Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Achieve Life Sciences is a clinical-stage pharmaceutical company engaged in the development and commercialization of cytisine for smoking cessation. Co.'s product candidate, cytisine, is a naturally occurring plant-based alkyloid from the seeds of the Laburnum anagyroides plant. Cytisine is a smoking cessation aid that interacts with nicotine receptors in the brain. Co. has a license and supply agreement with Sopharma, AD (Sopharma) for the development and commercialization of cytisine outside of Sopharma's territory, which consists of certain countries in Central and Eastern Europe, Scandinavia, North Africa, the Middle East and Central Asia, as well as Vietnam. According to our Achieve Life Science stock split history records, Achieve Life Science has had 2 splits.
Achieve Life Science stock split history picture
Achieve Life Science (ACHV) has 2 splits in our Achieve Life Science stock split history database. The first split for ACHV took place on August 03, 2017. This was a 1 for 11 reverse split, meaning for each 11 shares of ACHV owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 90.9090909090909 share position following the split. ACHV's second split took place on May 24, 2018. This was a 1 for 10 reverse split, meaning for each 10 shares of ACHV owned pre-split, the shareholder now owned 1 share. For example, a 90.9090909090909 share position pre-split, became a 9.09090909090909 share position following the split.

When a company such as Achieve Life Science conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the Achieve Life Science stock split history from start to finish, an original position size of 1000 shares would have turned into 9.09090909090909 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Achieve Life Science shares, starting with a $10,000 purchase of ACHV, presented on a split-history-adjusted basis factoring in the complete Achieve Life Science stock split history. Achieve Life Science split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 09/23/2008
End date: 09/21/2018
Start price/share: $451.00
End price/share: $2.49
Dividends collected/share: $0.00
Total return: -99.45%
Average Annual Total Return: -40.54%
Starting investment: $10,000.00
Ending investment: $55.24
Years: 10.00
Date Ratio
08/03/20171 for 11
05/24/20181 for 10
ACHV is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ACST Split History
ACUR Split History
ADK Split History
ADMP Split History
ADMS Split History
ADPT Split History
ADXS Split History
AEZS Split History
AFAM Split History
AFFX Split History

Also explore: ACHV shares outstanding history


More latest
Latest
Latest
Funds Holding Achieve Life Science